Banner
Generalized Anxiety Disorder Global Market Report 2024

Generalized Anxiety Disorder Global Market Report 2024 – By Type (Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types), By Therapies (Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy), By Device (Deep Brain Stimulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation), By End-User (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Generalized Anxiety Disorder Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Generalized Anxiety Disorder Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Generalized Anxiety Disorder Market Definition

Generalized anxiety disorder (GAD) is a mental health condition characterized by excessive and persistent worry, fear and anxiety about various aspects of life. It involves a broad range of concerns that can often feel uncontrollable and overwhelming. The treatment decisions change based on how significantly GAD is affecting a person's ability to function in daily life.

The main types of generalized anxiety disorder are panic disorder, agoraphobia, generalized anxiety, social anxiety, specific phobia and others. Panic disorder refers to a mental health condition characterized by recurring and unexpected episodes of intense fear and discomfort known as panic attacks. It can be treated by various therapies, such as interpersonal therapy, behavior therapy, cognitive behavioral therapy and mindfulness-based cognitive therapy, by using different types of devices, including deep brain stimulation, electroconvulsive therapy, transcranial magnetic stimulation and vagus nerve stimulation. These are utilized by hospitals, homecare, specialty clinics and others.

Generalized Anxiety Disorder Market Segmentation

The generalized anxiety disorder market covered in this report is segmented –

1) By Type: Panic Disorder; Agoraphobia; Generalized Anxiety; Social Anxiety; Specific Phobia; Other Types

2) By Therapies: Interpersonal Therapy; Behavior Therapy; Cognitive Behavioral Therapy; Mindfulness Based Cognitive Therapy

3) By Device: Deep Brain Stimulation; Electroconvulsive Therapy; Transcranial Magnetic Stimulation; Vagus Nerve Stimulation

4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users

Global Generalized Anxiety Disorder Market Size 2023 to 2028: Graph

Generalized Anxiety Disorder Market Size 2024 And Growth Rate

The generalized anxiety disorder market size has grown steadily in recent years. It will grow from $7.51 billion in 2023 to $7.76 billion in 2024 at a compound annual growth rate (CAGR) of 3.3%. The growth in the historic period can be attributed to mental health awareness, pharmaceutical advances, cognitive-behavioral therapy (cbt), stressful lifestyle changes.

Generalized Anxiety Disorder Market Growth Forecast

The generalized anxiety disorder market size is expected to see steady growth in the next few years. It will grow to $8.89 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to digital mental health solutions, genetic research, integrated care models, global mental health awareness. Major trends in the forecast period include holistic approaches, cultural competence, early intervention, artificial intelligence (ai) in diagnosis.

Generalized Anxiety Disorder Market Driver: Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder Market

The rising number of mental disorder cases in the healthcare industry is driving the growth of the generalized anxiety disorder market. A mental disorder, also known as a mental illness, refers to a wide range of conditions that affect a person's thoughts, emotions, behaviors and overall mental well-being. Mental health disorders that commonly occur with generalized anxiety disorder include phobias, panic disorder, post-traumatic stress disorder (PTSD) and obsessive-compulsive disorder (OCD) and managing these conditions is crucial for individuals to maintain healthy relationships and improve their quality of life. For instance, in April 2023, Forbes Media LLC, a US-based media company, reported that in 2020, 21% of U.S. adults (52.9 million) reported mental illness. Furthermore, in March 2023, according to the National Alliance on Mental Illness, a US-based non-profit organization, 22.8% (57.8 million people) of U.S. adults experienced mental illness in 2021, which increased from previous years. Therefore, the rising number of mental disorder cases is expected to propel the growth of the generalized anxiety disorder market.

Generalized Anxiety Disorder Market Driver: Government Initiatives Fueling Growth In The Generalized Anxiety Disorder (GAD) Market

Growing government initiatives are driving the growth of the generalized anxiety disorder market. A government initiative is a plan or action taken by a government to address a specific problem or issue that can be funded by various sources, including taxes, grants, and donations. Government initiatives are used to address generalized anxiety disorder (GAD) by funding research that can help to understand the causes and treatment of GAD better and to develop new and more effective ways to help people with this condition. For instance, in March 2022, the Department of Health and Human Services (HHS), a US-based provider of essential human services, announced funding possibilities totaling almost $35 million to improve and grow community mental health services and suicide prevention initiatives for children and young people in America. Therefore, the growing government initiatives are expected to propel the growth of the generalized anxiety disorder market.

Global Generalized Anxiety Disorder Market Major Players

Major players in the generalized anxiety disorder market are Alkermes PLC, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, 3M Company, Boehringer Ingelheim International GmbH, Johnson And Johnson Private Limited, Adobe Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals PLC, Forest Laboratories Inc., H. Lundbeck A/S, Shionogi and Company, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Noven Pharmaceuticals Inc., Mind Medicine Inc., Sage Therapeutics Inc., Bionomics Ltd., Recordati Rare Diseases SARL, VistaGen Therapeutics Inc.

Global Generalized Anxiety Disorder Market Restraint: Insufficient Mental Health Service Access Impedes Generalized Anxiety Disorder (GAD) Market Growth

The limited availability of mental health services is affecting the growth of the generalized anxiety disorder market during forecast period. Individuals with GAD may have difficulty receiving timely and adequate care if mental health services are not easily available. This lack of access can lead to delayed diagnosis and treatment, aggravating symptoms and increasing the burden on patients. For instance, in March 2023, according to House of Commons, a UK-based government body, in the years 2021–2022, 3.25 million individuals are anticipated to have interacted with these services. This represents just 5.8% of the population, ranging from 2.7% of 65- to 69-year-olds to 14.8% of 11 to 15-year-olds and 13.9% of 16 to 19-year-olds. Therefore, the limited availability of mental health services is hindering the growth of the generalized anxiety disorder market.

Global Generalized Anxiety Disorder Market Trend: Innovative Drug Development Revolutionizes Generalized Anxiety Disorder Treatment

Major companies operating in the generalized anxiety disorder market are developing innovative drugs such as MM-120 and getting approval for the treatment of generalized anxiety disorder to better meet the needs of their existing consumers. Innovative drugs such as MM-120 aim to improve the management and outcomes of this mental health condition. For instance, in January 2022, Mind Medicine Inc., a US-based psychedelic medicine biotech company, received approval for an Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA), allowing the company’s phase IIb dose-optimization trial of MM-120 for the treatment of generalized anxiety disorder (GAD) to proceed. MM-120 is a small molecule that acts as a partial agonist of the 5-HT2A receptor. This receptor is involved in the regulation of mood, anxiety and perception. Moreover, MM-120 is thought to work by increasing serotonin levels in the brain and this could pave the way for other psychedelic compounds to be developed to treat mental health disorders.

Generalized Anxiety Disorder Market Merger And Acquisition: Big Health's Strategic Acquisition Enhances Digital Therapeutics For Mental Health

In July 2023, Big Health, a US-based digital therapeutics company, acquired Limbix Health Inc. for an undisclosed amount. With this acquisition, Big Health aims to make a strategic move that will allow the two companies to combine their expertise and resources to develop and deliver more effective digital therapeutics for mental health conditions. Limbix Health Inc. is a US-based digital therapeutics platform that provides mental health treatment for young people suffering from depression, anxiety and other mental illnesses.

Regional Outlook For The Global Generalized Anxiety Disorder Market

North America was the largest region in the generalized anxiety disorder market in 2023. The regions covered in generalized anxiety disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the generalized anxiety disorder market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generalized anxiety disorder market consists of revenues earned by entities by providing services such as exposure therapy, supportive psychotherapy, relaxation therapies, group therapy, stress management and self-care practices. The market value includes the value of related goods sold by the service provider or included within the service offering. The generalized anxiety disorder market also includes sales of pregabalin, hydroxyzine, beta-blockers, atypical antipsychotics and alprazolam. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The generalized anxiety disorder market research report is one of a series of new reports from The Business Research Company that provides generalized anxiety disorder market statistics, including generalized anxiety disorder industry global market size, regional shares, competitors with a generalized anxiety disorder market share, detailed generalized anxiety disorder market segments, market trends and opportunities and any further data you may need to thrive in the generalized anxiety disorder industry. This generalized anxiety disorder market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Generalized Anxiety Disorder Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $7.76 billion
Revenue Forecast In 2033 $8.89 billion
Growth Rate CAGR of 3.5% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types
2) By Therapies: Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy
3) By Device: Deep Brain Stimulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Alkermes plc; Pfizer Inc.; F. Hoffmann-La Roche AG; Sanofi SA; Bristol-Myers Squibb; GlaxoSmithKline plc; AstraZeneca plc; Abbott Laboratories; 3M Company; Boehringer Ingelheim International GmbH; Johnson And Johnson Private Limited; Adobe Inc.; Baxter International Inc.; Teva Pharmaceutical Industries Ltd.; Otsuka Holdings Co. Ltd.; Mylan N.V.; Sumitomo Pharma Co. Ltd.; Jazz Pharmaceuticals plc; Forest Laboratories Inc.; H. Lundbeck A/S; Shionogi and Company; Neurocrine Biosciences Inc.; Actavis Pharmaceutical Company; Eli Lilly and Company; Noven Pharmaceuticals Inc.; Mind Medicine Inc.; Sage Therapeutics Inc.; Bionomics Ltd.; Recordati Rare Diseases SARL; VistaGen Therapeutics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Generalized Anxiety Disorder Market Characteristics

    3. Generalized Anxiety Disorder Market Trends And Strategies

    4. Generalized Anxiety Disorder Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Generalized Anxiety Disorder Market Size and Growth

    5.1. Global Generalized Anxiety Disorder Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Generalized Anxiety Disorder Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Generalized Anxiety Disorder Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Generalized Anxiety Disorder Market Segmentation

    6.1. Global Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Panic Disorder

    Agoraphobia

    Generalized Anxiety

    Social Anxiety

    Specific Phobia

    Other Types

    6.2. Global Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Interpersonal Therapy

    Behavior Therapy

    Cognitive Behavioral Therapy

    Mindfulness Based Cognitive Therapy

    6.3. Global Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Deep Brain Stimulation

    Electroconvulsive Therapy

    Transcranial Magnetic Stimulation

    Vagus Nerve Stimulation

    6.4. Global Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Homecare

    Specialty Clinics

    Other End-Users

    7. Generalized Anxiety Disorder Market Regional And Country Analysis

    7.1. Global Generalized Anxiety Disorder Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Generalized Anxiety Disorder Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Generalized Anxiety Disorder Market  

    8.1. Asia-Pacific Generalized Anxiety Disorder Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Generalized Anxiety Disorder Market  

    9.1. China Generalized Anxiety Disorder Market Overview  

    9.2. China Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Generalized Anxiety Disorder Market  

    10.1. India Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Generalized Anxiety Disorder Market  

    11.1. Japan Generalized Anxiety Disorder Market Overview  

    11.2. Japan Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Generalized Anxiety Disorder Market  

    12.1. Australia Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Generalized Anxiety Disorder Market  

    13.1. Indonesia Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Generalized Anxiety Disorder Market  

    14.1. South Korea Generalized Anxiety Disorder Market Overview  

    14.2. South Korea Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Generalized Anxiety Disorder Market  

    15.1. Western Europe Generalized Anxiety Disorder Market Overview

    15.2. Western Europe Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Generalized Anxiety Disorder Market  

    16.1. UK Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Generalized Anxiety Disorder Market  

    17.1. Germany Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Generalized Anxiety Disorder Market  

    18.5. France Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Generalized Anxiety Disorder Market  

    19.9. Italy Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Generalized Anxiety Disorder Market  

    20.13. Spain Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Generalized Anxiety Disorder Market  

    21.1. Eastern Europe Generalized Anxiety Disorder Market Overview

    21.2. Eastern Europe Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Generalized Anxiety Disorder Market  

    22.1. Russia Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Generalized Anxiety Disorder Market  

    23.1. North America Generalized Anxiety Disorder Market Overview

    23.2. North America Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Generalized Anxiety Disorder Market  

    24.1. USA Generalized Anxiety Disorder Market Overview

    24.2. USA Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Generalized Anxiety Disorder Market  

    25.1. Canada Generalized Anxiety Disorder Market Overview

    25.2. Canada Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Generalized Anxiety Disorder Market  

    26.1. South America Generalized Anxiety Disorder Market Overview

    26.2. South America Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Generalized Anxiety Disorder Market  

    27.1. Brazil Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Generalized Anxiety Disorder Market  

    28.1. Middle East Generalized Anxiety Disorder Market Overview

    28.2. Middle East Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Generalized Anxiety Disorder Market  

    29.1. Africa Generalized Anxiety Disorder Market Overview

    29.2. Africa Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Generalized Anxiety Disorder Market Competitive Landscape And Company Profiles

    30.1. Generalized Anxiety Disorder Market Competitive Landscape

    30.2. Generalized Anxiety Disorder Market Company Profiles

    30.2.1. Alkermes plc

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Pfizer Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. F. Hoffmann-La Roche AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Sanofi SA

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bristol-Myers Squibb

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Generalized Anxiety Disorder Market Other Major And Innovative Companies

    31.1. GlaxoSmithKline plc

    31.2. AstraZeneca plc

    31.3. Abbott Laboratories

    31.4. 3M Company

    31.5. Boehringer Ingelheim International GmbH

    31.6. Johnson And Johnson Private Limited

    31.7. Adobe Inc.

    31.8. Baxter International Inc.

    31.9. Teva Pharmaceutical Industries Ltd.

    31.10. Otsuka Holdings Co. Ltd.

    31.11. Mylan N.V.

    31.12. Sumitomo Pharma Co. Ltd.

    31.13. Jazz Pharmaceuticals plc

    31.14. Forest Laboratories Inc.

    31.15. H. Lundbeck A/S

    32. Global Generalized Anxiety Disorder Market Competitive Benchmarking

    33. Global Generalized Anxiety Disorder Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Generalized Anxiety Disorder Market

    35. Generalized Anxiety Disorder Market Future Outlook and Potential Analysis

    35.1 Generalized Anxiety Disorder Market In 2028 - Countries Offering Most New Opportunities

    35.2 Generalized Anxiety Disorder Market In 2028 - Segments Offering Most New Opportunities

    35.3 Generalized Anxiety Disorder Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Generalized Anxiety Disorder Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Generalized Anxiety Disorder Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Alkermes plc Financial Performance
  • Table 76: Pfizer Inc. Financial Performance
  • Table 77: F. Hoffmann-La Roche AG Financial Performance
  • Table 78: Sanofi SA Financial Performance
  • Table 79: Bristol-Myers Squibb Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Generalized Anxiety Disorder Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Generalized Anxiety Disorder Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Alkermes plc Financial Performance
  • Figure 76: Pfizer Inc. Financial Performance
  • Figure 77: F. Hoffmann-La Roche AG Financial Performance
  • Figure 78: Sanofi SA Financial Performance
  • Figure 79: Bristol-Myers Squibb Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the generalized anxiety disorder market?

Generalized anxiety disorder (GAD) is a mental health condition characterized by excessive and persistent worry, fear and anxiety about various aspects of life. It involves a broad range of concerns that can often feel uncontrollable and overwhelming. The treatment decisions change based on how significantly GAD is affecting a person's ability to function in daily life. request a sample here

How will the generalized anxiety disorder market drivers and restraints affect the generalized anxiety disorder market dynamics? What forces will shape the generalized anxiety disorder industry going forward?

The generalized anxiety disorder market major growth driver - Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder Market. request a sample here

What is the forecast market size or the forecast market value of the generalized anxiety disorder market?

The generalized anxiety disorder market size has grown steadily in recent years. It will grow from $7.51 billion in 2023 to $7.76 billion in 2024 at a compound annual growth rate (CAGR) of 3.3%. The growth in the historic period can be attributed to mental health awareness, pharmaceutical advances, cognitive-behavioral therapy (cbt), stressful lifestyle changes. The generalized anxiety disorder market size is expected to see steady growth in the next few years. It will grow to $8.89 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to digital mental health solutions, genetic research, integrated care models, global mental health awareness. Major trends in the forecast period include holistic approaches, cultural competence, early intervention, artificial intelligence (ai) in diagnosis. request a sample here

How is the generalized anxiety disorder market segmented?

The generalized anxiety disorder market is segmented
1) By Type: Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types
2) By Therapies: Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy
3) By Device: Deep Brain Stimulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-UsersFor further insights on the generalized anxiety disorder market
request a sample here

Which region has the largest share of the generalized anxiety disorder market? What are the other regions covered in the report?

North America was the largest region in the generalized anxiety disorder market in 2023. The regions covered in generalized anxiety disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the generalized anxiety disorder market?

Major players in the generalized anxiety disorder market are Alkermes PLC, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, 3M Company, Boehringer Ingelheim International GmbH, Johnson And Johnson Private Limited, Adobe Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals PLC, Forest Laboratories Inc., H. Lundbeck A/S, Shionogi and Company, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Noven Pharmaceuticals Inc., Mind Medicine Inc., Sage Therapeutics Inc., Bionomics Ltd., Recordati Rare Diseases SARL, VistaGen Therapeutics Inc. request a sample here.

What are the key trends in the generalized anxiety disorder market?

Major trend in the generalized anxiety disorder market - Innovative Drug Development Revolutionizes Generalized Anxiety Disorder Treatment. request a sample here.

What are the major opportunities in the generalized anxiety disorder market? What are the strategies for the generalized anxiety disorder market?

For detailed insights on the major opportunities and strategies in the generalized anxiety disorder market, request a sample here.

How does the generalized anxiety disorder market relate to the overall economy and other similar markets?

For detailed insights on generalized anxiety disorder market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the generalized anxiety disorder industry?

For detailed insights on the mergers and acquisitions in the generalized anxiety disorder industry, request a sample here.

What are the key dynamics influencing the generalized anxiety disorder market growth? SWOT analysis of the generalized anxiety disorder market.

For detailed insights on the key dynamics influencing the generalized anxiety disorder market growth and SWOT analysis of the generalized anxiety disorder industry, request a sample here.